Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression.
Mah
Linda
L
Kunin-Lunenfeld Applied Research Unit, Rotman Research Institute, Baycrest, University of Toronto, Toronto, ON, Canada. lmah@klaru-baycrest.on.ca
Zarate
Carlos A
CA
Nugent
Allison C
AC
Singh
Jaskaran B
JB
Manji
Husseini K
HK
Drevets
Wayne C
WC
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000627:therapeutic use*; D052160:Benzothiazoles / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D018491:Dopamine Agonists / Q000627:therapeutic use*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D006801:Humans; D008032:Limbic System / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010919:Placebos; D000077487:Pramipexole; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism*; D019275:Radiopharmaceuticals / Q000494:pharmacology
D000928:Antidepressive Agents; D018692:Antimanic Agents; D052160:Benzothiazoles; D018491:Dopamine Agonists; D010919:Placebos; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000077487:Pramipexole